Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
RenuYou is a biotechnology company focused on longevity and regenerative medicine, specifically through the application of non-viral gene therapies. The company is best known for its follistatin gene therapy, which utilizes a proprietary minicircle DNA platform to promote muscle growth and metabolic health. By operating in the Prospera ZEDE in Honduras, RenuYou leverages a unique regulatory framework to accelerate the clinical development and accessibility of its therapies. Their approach aims to treat age-related conditions such as sarcopenia and obesity by modulating key biological pathways like the myostatin/follistatin axis. The company's platform is designed to be safer and more durable than traditional viral-vector-based gene therapies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on RenuYou.